CD63 and breast cancer: Interestingly, urinary sEVs from early-stage BC patients had significantly higher levels of matrix metalloproteinase-1 (MMP-1)/CD63 than healthy control subjects, showing a high sensitivity for primary screening of early-stage BC cases [160].